Skip to main content
. 2015 Nov 19;20(11):20551–20568. doi: 10.3390/molecules201119717

Table 4.

Examples of current clinical trials targeting PHDs.

Drug Patient Population (Clinical Trial Phase) Purpose of Study Clinical Trials. Gov. Number (Status)
FG-4592 Subjects with anemia associated with chronic kidney disease without dialysis (phase III) Evaluate the efficacy for treatment of anemia correction and hemoglobin correction as well as their maintenance NCT01750190 (recruiting)
AKB-6548 Subjects with end stage renal disease undergoing chronic hemodialysis (phase II) Evaluate the hemoglobin response (efficacy), safety, and tolerability NCT02260193 (activated, but not recruiting)
GSK-1278863 Hemodialysis dependent subjects with anemia associated with chronic kidney diseases, chronically hyporesponsive to recombinant human EPO (phase II) Evaluate the safety and efficacy after switching from recombinant human EPO NCT02075463 (recruiting)
BAY-85-3934 Subjects with anemia associated with chronic kidney disease on dialysis, in USA and Japan (phase II) Evaluate the efficacy and safety of oral BAY-85-3934 and active comparator in the long term treatment NCT02064426 (recruiting)